Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis
- PMID: 26886628
- PMCID: PMC4998628
- DOI: 10.1097/MD.0000000000002793
Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis
Erratum in
- 
  
  Erratum: Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis: Erratum.Medicine (Baltimore). 2016 May 20;95(20):e6650. doi: 10.1097/01.md.0000484108.92666.50. eCollection 2016 May. Medicine (Baltimore). 2016. PMID: 31265583 Free PMC article.
Abstract
Use of Chinese herbal medicines (CHM) in symptom management for cancer palliative care is very common in Chinese populations but clinical evidence on their effectiveness is yet to be synthesized. To conduct a systematic review with meta-analysis to summarize results from CHM randomized controlled trials (RCTs) focusing on symptoms that are undertreated in conventional cancer palliative care.Five international and 3 Chinese databases were searched. RCTs evaluating CHM, either in combination with conventional treatments or used alone, in managing cancer-related symptoms were considered eligible. Effectiveness was quantified by using weighted mean difference (WMD) using random effect model meta-analysis. Fourteen RCTs were included. Compared with conventional intervention alone, meta-analysis showed that combined CHM and conventional treatment significantly reduced pain (3 studies, pooled WMD: -0.90, 95% CI: -1.69 to -0.11). Six trials comparing CHM with conventional medications demonstrated similar effect in reducing constipation. One RCT showed significant positive effect of CHM plus chemotherapy for managing fatigue, but not in the remaining 3 RCTs. The additional use of CHM to chemotherapy does not improve anorexia when compared to chemotherapy alone, but the result was concluded from 2 small trials only. Adverse events were infrequent and mild. CHM may be considered as an add-on to conventional care in the management of pain in cancer patients. CHM could also be considered as an alternative to conventional care for reducing constipation. Evidence on the use of CHM for treating anorexia and fatigue in cancer patients is uncertain, warranting further research.
Conflict of interest statement
VCHC is Honorary Research Fellow of the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), Faculty of Health, University of Technology Sydney, Sydney, Australia. The remaining authors declare no conflict of interest.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - The Lancet. Moving cancer up the global health agenda. The Lancet 2010; 375:2051. - PubMed
 
- 
    - Deshields TL, Potter P, Olsen S, et al. Documenting the symptom experience of cancer patients. J Support Oncol 2011; 9:216–223. - PubMed
 
- 
    - Pachman DR, Barton DL, Swetz KM, et al. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol 2012; 30:3687–3696. - PubMed
 
- 
    - Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care—Part II: cachexia/anorexia and fatigue. J Palliat Med 2006; 9:409–421. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        